GreenLight and US NIH partner to develop Covid-19 vaccine for variants
Pharmaceutical Technology
AUGUST 1, 2022
They intend to develop vaccines that provide lasting immune responses compared to existing vaccines. The human health product candidates of GreenLight are currently in the pre-clinical stage. Furthermore, the parties will collaborate on the joint development of systems that accelerate the latest designs into clinical usage.
Let's personalize your content